Jason Oneill

Director, Protein Chemistry @Omeros Corporation

Seattle, WA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2023 — Present

Director, Protein Chemistry @Omeros Corporation

View department →

Seattle, WA, US

EDUCATION

1988 — 1991

UC San Diego

BS, Biology

1994 — 2001

University of Washington

PhD, Protein Biochemistry, X-ray Crystallography

SKILLS

Protein CharacterizationResearchProtein PurificationBiochemistryMonoclonal AntibodiesProtein ChromatographyManagementMolecular BiologyProtein EngineeringChromatographyCell BiologyDrug DevelopmentOncologyBiopharmaceuticalsProject ManagementOperations ManagementCell CultureX-Ray CrystallographyBiotechnology IndustryHplcPcrPurificationProtein ExpressionProtein ChemistryBiophysicsAntibodies

ABOUT JASON ONEILL

Director, Protein Sciences. Protein Engineering & Therapeutic DiscoveryProtein science leader with 20 years of experience in biotechnology, specializing in structure-based engineering of therapeutic modalities. Proven track record on directing cross-functional teams and integrating technical strategies towards the advancment of protein biologics through discovery and early process development.Protein Engineering & ProductionExpert in research-scale purification process development and analytical characterization of preclinical biologics. Skilled in building high-throughput, small- and mid-scale platforms for protein and antibody (Ab) purification. Leverage deep expertise in protein structure and modeling to accelerate development of therapeutic proteins and diverse Ab formats. Extensive experience with bioconjugation strategies, supporting ADC and peptide/protein conjugate programs.Technical Project ManagementDeep understanding of early discovery and lead optimization, including modality selection, manufacturability, and potency. Strong grounding in disease biology enables effective collaboration with multidisciplinary teams to identify therapeutic paths and nominate lead candidates. Known for aligning technical execution with program goals to drive advancement of preclinical assets.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.